Chemomab Therapeutics Ltd. (CMMB)
1.66
-0.04
(-2.35%)
USD |
NASDAQ |
Jan 16, 16:00
1.66
0.00 (0.00%)
After-Hours: 20:00
Chemomab Therapeutics EPS Diluted (Quarterly): -0.2829 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0746 |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | -5.546 |
| Nasus Pharma Ltd. | -- |
| Regentis Biomaterials Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.750M |
| Total Expenses (Quarterly) | 1.750M |
| Enterprise Value | 0.0125M |
| Earnings Yield | -112.0% |
| Normalized Earnings Yield | -111.98 |